Log in

Relevant bibliographies by topics / Chronic disease / Journal articles

To see the other types of publications on this topic, follow the link: Chronic disease.

Journal articles on the topic 'Chronic disease'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Chronic disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

S, Memon. "Hyponatremia in Chronic Kidney Disease." Open Access Journal of Urology & Nephrology 7, no. 2 (2022): 1–7. http://dx.doi.org/10.23880/oajun-16000202.

Full text

Abstract:

Introduction: There is adequate literature written on hyponatremia, but not much seen in context of Chronic Kidney Disease (CKD). Patients become prone for this electrolyte derangement when they are afflicted with organ failure especially CKD. This vulnerability becomes even worse in ageing due to impaired sensitivity to fluid intake and often burdened with multiple comorbid. For the adequate management of hyponatremia, knowledge of volume status, age of patients and associated comorbid, and duration of hyponatremia are very important. Patients and Methods: This observational study was conduct

APA, Harvard, Vancouver, ISO, and other styles

2

Parmar, Dr Jigar A., Anant G. Joshi, and Dr Manish Chakrabarti. "Dyslipidemia and Chronic Kidney Disease." International Journal of Scientific Research 3, no. 5 (2012): 396–97. http://dx.doi.org/10.15373/22778179/may2014/123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

L Pathan, Fayaj. "Nonalcoholic Fatty Liver Disease (NAFLD) A Chronic Liver Disease." Acta Scientifci Nutritional Health 4, no. 1 (2019): 58. http://dx.doi.org/10.31080/asnh.2020.04.nonalcoholic-fatty-liver-disease-nafld-a-chronic-liver-disease.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hague, Andrew. "CellSonic cures chronic disease in a person. Sapiens Shield stops chronic disease in a population." Endocrine System and Diabetes 1, no. 1 (2023): 01–03. http://dx.doi.org/10.58489/2836-502x/001.

Full text

Abstract:

All humans and many other species get cancer. It happens daily. The body’s cells replicate on average every six weeks. With billions of cells, some of the new cells fail to be exact copies of the previous cells. The new ones are different and are mutations that we call cancer. Survival of the species depends on removing the wrong cells and this is done by the immune system at night during proper sleep.

APA, Harvard, Vancouver, ISO, and other styles

5

TN, Santhosh Kumar. "Osteoporosis in Chronic Obstructive Pulmonary Disease." Journal of Orthopedics & Bone Disorders 8, no. 3 (2024): 1–2. http://dx.doi.org/10.23880/jobd-16000270.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

singh, Jagroop. "Inflammatory Markers in Chronic Kidney Disease." Journal of Virology and Vaccination 1, no. 1 (2023): 01–05. http://dx.doi.org/10.58489/2836-6387/004.

Full text

Abstract:

Background: Despite recent advances in chronic kidney disease (CKD) and end-stage renal disease (ESRD) management, morbidity and mortality in this population remain exceptionally high. Persistent, low-grade inflammation has been recognized as an important component of CKD, playing a unique role in its pathophysiology and being accountable in part for cardiovascular and all-cause mortality, as well as contributing to the development of protein-energy wasting. Material and methods; This study was conducted on CKD patients attending OPD & IPD of Civil Hospital tarn taran. The participants hav

APA, Harvard, Vancouver, ISO, and other styles

7

Mal, Pooran, Muhammad Nadeem Ahsan, Mehwish Bukhari, and Abdul Manan Junejo. "CHRONIC KIDNEY DISEASE." Professional Medical Journal 25, no. 09 (2018): 1380–85. http://dx.doi.org/10.29309/tpmj/18.4360.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kent, Elizabeth. "Chronic Cardiac Disease Chronic Cardiac Disease." Nursing Standard 17, no. 22 (2003): 28. http://dx.doi.org/10.7748/ns2003.02.17.22.28.b331.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Nishi, Shinichi. "Chronic Kidney Disease and Cardiovascular Disease: Progression of Arterial Diseases in Chronic Kidney Disease." Nihon Naika Gakkai Zasshi 105, no. 5 (2016): 791–92. http://dx.doi.org/10.2169/naika.105.791.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fatima, Tanveer, Aurangzeb Afzal, and Sania Ashraf. "CHRONIC KIDNEY DISEASE." Professional Medical Journal 25, no. 06 (2018): 887–91. http://dx.doi.org/10.29309/tpmj/18.4418.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

TONELLI, Marcello, and Miguel RIELLA. "Chronic Kidney Disease and the Aging Population." Turkish Nephrology Dialysis Transplantation 23, no. 01 (2014): 3–7. http://dx.doi.org/10.5262/tndt.2014.1001.02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kumar, Santosh. "Chronic Kidney Disease Pre and Post Hemodylasis." International Journal of Science and Research (IJSR) 12, no. 2 (2023): 356–58. http://dx.doi.org/10.21275/sr23204172603.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Rakesh, R., Dr G. S. Nishanthi, and Dr S. Kevin Andrews. "Chronic Kidney Disease Cast Using SML Technique." International Journal of Research Publication and Reviews 5, no. 5 (2024): 1884–93. http://dx.doi.org/10.55248/gengpi.5.0524.1137.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Gluhovschi, Gh, Ligia Petrica, I. Sporea, et al. "Chronic Kidney Disease – Chronic Liver Disease. An Immunologic Cross-talk." Romanian Journal Of Internal Medicine 53, no. 1 (2015): 3–12. http://dx.doi.org/10.1515/rjim-2015-0001.

Full text

Abstract:

Abstract The relationship between the kidney and other organs is notable. The bestknown is the relation with the cardiovascular system. Relationships with other organs are less studied, although their involvement sometimes dominates the clinical picture and the outcome of disease. The paper analyzes the kidney-liver relationship, namely chronic kidney disease and chronic liver disease from an immune viewpoint. The immune system operates as a unitary whole. There is an interdependence between the immune system of the liver, considered a lymphoid organ, and the kidney, whose participation in imm

APA, Harvard, Vancouver, ISO, and other styles

15

Dale, Marita T., and Mark R. Elkins. "Chronic disease." Journal of Physiotherapy 67, no. 2 (2021): 84–86. http://dx.doi.org/10.1016/j.jphys.2021.02.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Watkins, Peter. "Chronic disease." Clinical Medicine 4, no. 4 (2004): 297–98. http://dx.doi.org/10.7861/clinmedicine.4-4-297.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Beech, Bettina M. "Chronic Disease." Family & Community Health 36, no. 2 (2013): 95–96. http://dx.doi.org/10.1097/fch.0b013e3182867034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Porche, Demetrius J. "Chronic Disease." American Journal of Men's Health 5, no. 6 (2011): 465. http://dx.doi.org/10.1177/1557988311402052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

C Allen, M. Palta T LeCaire, G.-H. Huang, P. Brazy, and D. D'Alessio. "Chronic disease." Annals of Epidemiology 12, no. 7 (2002): 498. http://dx.doi.org/10.1016/s1047-2797(02)00310-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Russell, Richard, and Jayne Norcliffe. "Chronic obstructive pulmonary disease: management of chronic disease." Medicine 36, no. 4 (2008): 218–22. http://dx.doi.org/10.1016/j.mpmed.2008.01.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Russell, Richard, Jayne Norcliffe, and Mona Bafadhel. "Chronic obstructive pulmonary disease: management of chronic disease." Medicine 40, no. 5 (2012): 262–66. http://dx.doi.org/10.1016/j.mpmed.2012.02.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Hambleton, Kirsty, Mona Bafadhel, and Richard Russell. "Chronic obstructive pulmonary disease: management of chronic disease." Medicine 44, no. 5 (2016): 310–13. http://dx.doi.org/10.1016/j.mpmed.2016.02.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Ramakrishnan, Sanjay, Mona Bafadhel, and Richard Russell. "Chronic obstructive pulmonary disease: management of chronic disease." Medicine 48, no. 5 (2020): 333–36. http://dx.doi.org/10.1016/j.mpmed.2020.02.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

khatal, Sujata, Priya Nair, and U. B. Shetkar U.B.Shetkar. "Case Report of Acute on Chronic Pancreatitis with Hyperparathyroidism with Chronic Kidney Disease." Indian Journal of Applied Research 4, no. 3 (2011): 397–99. http://dx.doi.org/10.15373/2249555x/mar2014/124.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Parfenov, V. A. "Ménière’s disease and chronic cerebrovascular diseases." Meditsinskiy sovet = Medical Council, no. 19 (December 1, 2021): 35–40. http://dx.doi.org/10.21518/2079-701x-2021-19-35-40.

Full text

Abstract:

Ménière’s disease (MD) is an idiopathic inner ear disease, which is characterized by noise in the ears, periodic attacks of vertigo and the development of sensorineural hearing loss. MD is characterized by endolymphatic hydrops – an increase in the volume of endolymph that fills the membered labyrinth of the inner ear. Currently highlighted subtypes MD. The first subtype meets most often and is characterized by classical manifestations of MD. The second subtype is characterized by the development of sensorineural hearing loss, to which only after a long time are joined by the episodes of dizzi

APA, Harvard, Vancouver, ISO, and other styles

26

Sanai, Toru, Ken Okamura, Tsuyoshi Takashima, Motoaki Miyazono, and Yuji Ikeda. "Chronic kidney disease and thyroid diseases." Nihon Toseki Igakkai Zasshi 52, no. 11 (2019): 615–23. http://dx.doi.org/10.4009/jsdt.52.615.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

FAIVRE, M., and S. LACAN. "Bronchopneumopathie chronique obstructive." EXERCER 35, no. 199 (2024): 38–40. http://dx.doi.org/10.56746/exercer.2024.199.38.

Full text

Abstract:

Les recommandations internationales concernant la prise en charge de la bronchopneumopathie chronique obstructive (BPCO) ont été mises à jour par la Global Initiative for Chronic Obstructive Lung Disease (GOLD) en 20231. Cet article revient sur les modifications apportées par rapport à celles de 2022.

APA, Harvard, Vancouver, ISO, and other styles

28

M S, Champa, and Rekha B S. "Chronic Kidney Disease Detection Using Micro-service Architecture." International Journal of Innovative Research in Computer Science & Technology 7, no. 3 (2019): 84–89. http://dx.doi.org/10.21276/ijircst.2019.7.3.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Shivraj, Shivraj, and Venugopal K. "Gastrointestinal Manifestations in Patients with Chronic Kidney Disease." Academia Journal of Medicine 2, no. 2 (2019): 54–59. http://dx.doi.org/10.21276/ajm.2019.2.2.15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

VN, Karan, and Vishwanath VN. "Clinical Profile of Patients with Chronic Kidney Disease." Academia Journal of Medicine 2, no. 2 (2019): 175–78. http://dx.doi.org/10.21276/ajm.2019.2.2.45.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

(Medicine), Dr Ashok Kumar M. D. "Observation on Serum Magnesium in Chronic Kidney Disease." Journal of Medical Science And clinical Research 05, no. 05 (2017): 20570–72. http://dx.doi.org/10.18535/jmscr/v5i5.211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Ramraje, N. N. "Study of OSA in Chronic Obstructive Pulmonary Disease." Journal of Medical Science And clinical Research 05, no. 05 (2017): 21712–14. http://dx.doi.org/10.18535/jmscr/v5i5.78.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Tokgöz Akyıl, Fatma, Tülin Sevim, Safa Barış, et al. "Two Chronic Granulomatous Disease Diagnosed in Adult Age." Turkish Thoracic Journal 17, no. 4 (2016): 163–67. http://dx.doi.org/10.5578/ttj.30515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Peco-Antić, Amira. "How to grow up with chronic kidney disease?" Central European Journal of Paediatrics 14, no. 1 (2018): 37–46. http://dx.doi.org/10.5457/p2005-114.197.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Sulekha Chigiri, Sindu, Raghu V, Anil Kumar Bhupally, and Jeevika Nagula. "Ocular Manifestations in Patients with Chronic Kidney Disease." International Journal of Science and Research (IJSR) 10, no. 4 (2021): 403–5. https://doi.org/10.21275/sr21323161944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Redkar, Rutuja, and Megha Gaikwad. "Chronic Kidney Disease in Bone and Mineral Disorder." International Journal of Science and Research (IJSR) 10, no. 6 (2021): 1250–53. https://doi.org/10.21275/mr21620120318.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

G.K., Rakhmatullayeva, Artykova M.A., and Khudayarova S.M. "NEUROIMAGING CHARACTERISTICS OF ENCEPHALOPATHY IN CHRONIC KIDNEY DISEASE." American Journal of Medical Sciences and Pharmaceutical Research 05, no. 05 (2023): 24–29. http://dx.doi.org/10.37547/tajmspr/volume05issue05-07.

Full text

Abstract:

According to WHO, vascular diseases of the brain in the developed countries of the world account for 15% of the total mortality. At the same time, acute and chronic encephalopathies occupy a special place in the structure of vascular diseases. In recent years, special attention has been paid to encephalopathies developing as a result of renal pathology, since kidney diseases, namely chronic kidney disease (CKD) is a huge socio-economic problem that leads to cerebral complications, with a significant deterioration in the quality of life, a sharp loss of working capacity, and a high percentage o

APA, Harvard, Vancouver, ISO, and other styles

38

..., Vishakha, Pragya Sinha, Bandhu Sharma, and S. P. Subashini. "Efficacy of Growth Hormone in Chronic Kidney Disease." Indian Journal of Genetics and Molecular Research 11, no. 1 (2022): 29–30. http://dx.doi.org/10.21088/ijgmr.2319.4782.11122.3.

Full text

Abstract:

Children with chronic kidney disease (CKD) have difficulty achieving normal growth due to severe alterations in the growth hormone (GH) and insulin-like growth factor (IGF-1) axis. Recombinant human growth hormone (rhGH) therapy (GH). It encourages long-term growth and allows children with CKD to reach normal height.It has been demonstrated to be both safe and effective. After a kidney transplant, growth retardation may remain. Multiple variables, such as steroid use, impaired renal function, and an aberrant GH axis, have contributed to this condition.

APA, Harvard, Vancouver, ISO, and other styles

39

Amrelevich, Akhmedov Ibrat. "CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION." American Journal of Medical Sciences and Pharmaceutical Research 6, no. 5 (2024): 15–17. http://dx.doi.org/10.37547/tajmspr/volume06issue05-04.

Full text

Abstract:

The article presents the results of assessing the state of kidney function in patients with arterial hypertension. The study used a method for calculating the glomerular filtration rate according to the expanded formula for determining creatinine in the blood.

APA, Harvard, Vancouver, ISO, and other styles

40

Galil, A. G. D. S., B. A. B. B. Andrade, M. M. Gusmão, et al. "PO393 Chronic Kidney Disease in Smokers with Multiple Chronic Diseases." Global Heart 13, no. 4 (2018): 461. http://dx.doi.org/10.1016/j.gheart.2018.09.303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Betancourt, M. T., K. C. Roberts, T.-L. Bennett, E. R. Driscoll, G. Jayaraman, and L. Pelletier. "Monitoring chronic diseases in Canada: the Chronic Disease Indicator Framework." Chronic Diseases and Injuries in Canada 34, Supplement 1 (2014): 1–30. http://dx.doi.org/10.24095/hpcdp.34.s1.01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Shtarik, S. Yu, S. S. Bogomolova, M. M. Petrova, L. K. Danilova, E. V. Zorina, and E. A. Pronina. "Combination of chronic kidney disease with chronic non-infectious diseases." Yakut Medical Journal, no. 2 (June 22, 2025): 118–23. https://doi.org/10.25789/ymj.2025.90.25.

Full text

Abstract:

The scientific review examines chronic kidney disease (CKD) in combination with chronic non-communicable diseases. Chronic kidney disease is a serious and growing public health problem worldwide, characterized by a gradual and irreversible decline in kidney function and is one of the leading causes of death worldwide. The priority task of healthcare is the prevention of chronic non-communicable diseases, among which the most significant include cardiovascular diseases, bronchopulmonary diseases, diabetes mellitus, and oncological diseases. The association of CKD with chronic non-communicable d

APA, Harvard, Vancouver, ISO, and other styles

43

van Eeden, Stephan F., and Don D. Sin. "Chronic Obstructive Pulmonary Disease: A Chronic Systemic Inflammatory Disease." Respiration 75, no. 2 (2007): 224–38. http://dx.doi.org/10.1159/000111820.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Cho, Sung-il. "The coronavirus disease 2019 pandemic and chronic diseases." Journal of the Korean Medical Association 65, no. 10 (2022): 628–31. http://dx.doi.org/10.5124/jkma.2022.65.10.628.

Full text

Abstract:

Background: Chronic diseases contribute to 74% of annual global deaths. The coronavirus disease (COVID-19) pandemic further aggravated the burden of chronic diseases. The reasons for this adverse impact must be elucidated to develop an appropriate response.Current Concepts: COVID-19 increases the burden of chronic disease in three ways. First, chronic disease comorbidities are associated with a higher severity and fatality rate in patients with COVID-19. Second, the post COVID-19 condition results in chronic health problems. Lastly, a disruption in the system for chronic disease screening and

APA, Harvard, Vancouver, ISO, and other styles

45

Chen, Jacqueline, and Ria Patel. "Chronic Kidney Disease." Meducator 1, no. 44 (2024): 20–21. http://dx.doi.org/10.15173/m.v1i44.3620.

Full text

Abstract:

Chronic kidney disease (CKD) is defined as low filtration function in the kidneys, protein in the urine, or functionally-important structural abnormalities. Low filtration function is associated with waste build-up in the bloodstream and difficulty in excreting salt and water, leading to fluid build-up. CKD may worsen over time, and some individuals with CKD may experience kidney failure, at which point dialysis or transplantation is required to replace kidney function. CKD may be caused by diabetes, renovascular disease, glomerulonephritis, polycystic kidney disease, and various genetic and e

APA, Harvard, Vancouver, ISO, and other styles

46

Jeong, Hae, and Dong Kim. "Bone Diseases in Patients with Chronic Liver Disease." International Journal of Molecular Sciences 20, no. 17 (2019): 4270. http://dx.doi.org/10.3390/ijms20174270.

Full text

Abstract:

Osteoporosis is a frequently observed complication in patients with chronic liver disease, particularly liver cirrhosis and cholestatic liver diseases. In addition, osteoporosis is critical in patients receiving a liver transplant. Nevertheless, few studies have evaluated bone diseases in patients with more frequently observed chronic liver disease, such as chronic viral hepatitis, nonalcoholic fatty liver disease and alcoholic liver disease. Osteoporosis is a disease caused by an imbalance in the activities of osteoblasts and osteoclasts. Over the last few decades, many advances have improved

APA, Harvard, Vancouver, ISO, and other styles

47

Bu, Jia, and Cui-Ping Xu. "Chronic constipation and chronic disease management." World Chinese Journal of Digestology 24, no. 30 (2016): 4162. http://dx.doi.org/10.11569/wcjd.v24.i30.4162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Gálvez, Alyshia, Megan Carney, and Emily Yates‐Doerr. "Chronic Disaster: Reimagining Noncommunicable Chronic Disease." American Anthropologist 122, no. 3 (2020): 639–40. http://dx.doi.org/10.1111/aman.13437.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

McAlister, G., and G. McPartlin. "CHRONIC DISEASE MANAGEMENT – CHRONIC FATIGUE SYNDROME." Journal of the Royal College of Physicians of Edinburgh 32, no. 2 (2002): 122–33. https://doi.org/10.1177/1478271520023202013.

Full text

Abstract:

Whilst debate continues around the aetiology, classification and treatment of chronic fatigue syndrome (CFS), the authors report on a successful case of chronic disease management during a time in which little clinical evidence on the most effective methods of treatment was available; question whether this protracted, and polarised, debate may have had a detrimental impact upon sufferers of this condition; and also advocate a more holistic approach to the treatment of medically unexplained symptoms in general.

APA, Harvard, Vancouver, ISO, and other styles

50

Ball, Timothy, Kevin Wheelan, and Peter A. McCullough. "Chronic Anticoagulation in Chronic Kidney Disease∗." Journal of the American College of Cardiology 64, no. 23 (2014): 2483–85. http://dx.doi.org/10.1016/j.jacc.2014.09.052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!